APA

Mathews V., Desire S., George B., Lakshmi K. M., Rao J. G., Viswabandya A., Bajel A., Srivastava V. M., Srivastava A. & Chandy M. (20060912). Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity. : Leukemia.

Chicago

Mathews V, Desire S, George B, Lakshmi K M, Rao J G, Viswabandya A, Bajel A, Srivastava V M, Srivastava A and Chandy M. 20060912. Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity. : Leukemia.

Harvard

Mathews V., Desire S., George B., Lakshmi K. M., Rao J. G., Viswabandya A., Bajel A., Srivastava V. M., Srivastava A. and Chandy M. (20060912). Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity. : Leukemia.

MLA

Mathews V, Desire S, George B, Lakshmi K M, Rao J G, Viswabandya A, Bajel A, Srivastava V M, Srivastava A and Chandy M. Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity. : Leukemia. 20060912.